Berker D - Search Results

1

Comparison of alendronate and raloxifene for the management of primary hyperparathyroidism.

Akbaba G, Isik S, Ates Tutuncu Y, Ozuguz U, Berker D, Guler S. Akbaba G, et al. Among authors: berker d. J Endocrinol Invest. 2013 Dec;36(11):1076-82. doi: 10.3275/9095. Epub 2013 Sep 27. J Endocrinol Invest. 2013. PMID: 24081023 Clinical Trial.

2

A comparative study of pre-operative imaging methods in patients with primary hyperparathyroidism: ultrasonography, 99mTc sestamibi, single photon emission computed tomography, and magnetic resonance imaging.

Akbaba G, Berker D, Isik S, Aydin Y, Ciliz D, Peksoy I, Ozuguz U, Tutuncu YA, Guler S. Akbaba G, et al. Among authors: berker d. J Endocrinol Invest. 2012 Apr;35(4):359-64. doi: 10.3275/7764. Epub 2011 May 27. J Endocrinol Invest. 2012. PMID: 21623148

3

Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience.

Arduc A, Gokay F, Isik S, Ozuguz U, Akbaba G, Tutuncu Y, Berker D, Kucukler FK, Aydin Y, Guler S. Arduc A, et al. Among authors: berker d. J Endocrinol Invest. 2015 Apr;38(4):447-53. doi: 10.1007/s40618-014-0212-4. Epub 2014 Nov 25. J Endocrinol Invest. 2015. PMID: 25421155

4

Somatotropin adenoma and resistance to thyroid hormone.

Berker D, Aydin Y, Tutuncu YA, Isik S, Delibasi T, Berker M, Guler S, Kamel N. Berker D, et al. Among authors: berker m. J Endocrinol Invest. 2009 Mar;32(3):284-6. doi: 10.1007/BF03346468. J Endocrinol Invest. 2009. PMID: 19542750

5

Obstructive sleep apnea syndrome and its association with vitamin D deficiency.

Mete T, Yalcin Y, Berker D, Ciftci B, Guven SF, Topaloglu O, Yavuz HC, Guler S. Mete T, et al. Among authors: berker d. J Endocrinol Invest. 2013 Oct;36(9):681-5. doi: 10.3275/8923. Epub 2013 Apr 2. J Endocrinol Invest. 2013. PMID: 23558409

6

Characterization of V804M-mutated RET proto-oncogene associated with familial medullary thyroid cancer, report of the largest Turkish family.

Basaran MN, Tuna MM, Karakılıç E, Doğan BA, İmga NN, Berker D, Güler S. Basaran MN, et al. Among authors: berker d. J Endocrinol Invest. 2015 May;38(5):541-6. doi: 10.1007/s40618-014-0224-0. Epub 2014 Dec 12. J Endocrinol Invest. 2015. PMID: 25501606

7

EXENATIDE TREATMENT REDUCES THYROID GLAND VOLUME, BUT HAS NO EFFECT ON THE SIZE OF THYROID NODULES.

Köseoğlu D, Özdemir Başer Ö, Berker D, Güler S. Köseoğlu D, et al. Among authors: berker d. Acta Endocrinol (Buchar). 2020 Jul-Sep;16(3):275-279. doi: 10.4183/aeb.2020.275. Acta Endocrinol (Buchar). 2020. PMID: 33363646 Free PMC article.

8

Clinical presentation of Von Hippel Lindau syndrome type 2B associated with VHL p.A149S mutation in a large Turkish family.

Mete T, Berker D, Yilmaz E, Ozgen G, Yalcin Y, Tuna M, Ciliz D, Onen M, Aydin Y, Guler S. Mete T, et al. Among authors: berker d. Endocrine. 2014 Feb;45(1):128-35. doi: 10.1007/s12020-013-9982-2. Epub 2013 May 15. Endocrine. 2014. PMID: 23673869

9

Evaluation of carotid intima media thickness in impaired fasting glucose and impaired glucose tolerance.

Aydin Y, Berker D, Ustün I, Gül K, Erden G, Kutlucan A, Yilmaz Aydin L, Güler S. Aydin Y, et al. Among authors: berker d. Minerva Endocrinol. 2011 Sep;36(3):171-9. Minerva Endocrinol. 2011. PMID: 22019748

10

Increased Risk of Unfavorable Metabolic Outcome in Patients with Clinically Nonfunctioning Pituitary Adenomas.

Doğan BA, Tuna MM, Arduç A, Başaran MN, Küçükler K, Dağdelen I, Berker D, Güler S. Doğan BA, et al. Among authors: berker d. Horm Metab Res. 2015 Aug;47(9):652-5. doi: 10.1055/s-0035-1547234. Epub 2015 Mar 6. Horm Metab Res. 2015. PMID: 25750077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters